Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis

Abstract Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced risk of hospitalization and death, different adverse events may presen...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Matteo Castaldo, Marta Waliszewska-Prosół, Maria Koutsokera, Micaela Robotti, Marcin Straburzyński, Loukia Apostolakopoulou, Mariarita Capizzi, Oneda Çibuku, Fidel Dominique Festin Ambat, Ilaria Frattale, Zukhra Gadzhieva, Erica Gallo, Anna Gryglas-Dworak, Gleni Halili, Asel Jusupova, Yana Koperskaya, Alo-Rainer Leheste, Maria Laura Manzo, Andrea Marcinnò, Antonio Marino, Petr Mikulenka, Bee Eng Ong, Burcu Polat, Zvonimir Popovic, Eduardo Rivera-Mancilla, Adina Maria Roceanu, Eleonora Rollo, Marina Romozzi, Claudia Ruscitto, Fabrizio Scotto di Clemente, Sebastian Strauss, Valentina Taranta, Maria Terhart, Iryna Tychenko, Simone Vigneri, Blazej Misiak, Paolo Martelletti, Alberto Raggi, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2022-03-01
Sarja:	The Journal of Headache and Pain
Aiheet:	SARS-CoV-2 COVID-19 Vaccination Headache BNT162b2 ChAdOx1
Linkit:	https://doi.org/10.1186/s10194-022-01400-4
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!